Skip to content

Denosumab (Prolia) in Dialysis Patients: Risk of Severe Hypocalcemia – Causes, Case, and Prevention

🧬 What Is Denosumab (Prolia)? Denosumab (Prolia®, generic name: denosumab) is a RANKL inhibitor that blocks the activity of osteoclasts, the cells responsible for bone resorption. It is used in various conditions: Postmenopausal osteoporosis Glucocorticoid-induced… Denosumab (Prolia) in Dialysis Patients: Risk of Severe Hypocalcemia – Causes, Case, and Prevention